Tumor promotion by metanil yellow and malachite green during rat hepatocarcinogenesis is associated with dysregulated expression of cell cycle regulatory proteins

Teratogenesis Carcinogenesis and Mutagenesis

Volumn , Issue SUPPL. 1, 2003, Pages 301-312

  Gupta, Sanjay ^a   Sundarrajan, Monisha ^a   Rao, K V K ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cyclin cdk; Hepatocellular carcinoma; Malachite green (MG); Metanil yellow (MY); N nitrosodiethylamine (DEN)

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN B1; CYCLIN D1; MALACHITE GREEN; METANIL YELLOW; PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALIA; SIPROETA STELENES;

EID: 0037289199     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/tcm.10056     Document Type: Conference Paper

References (37)

1. Khanna SK, Singh SB. Non-permitted colours in food and their toxicity. J Food Sci Technol 1973;10:33.
2. Joint FAO/WHO Expert Committee on food additives, 8th report, WHO Tech Ser No.309 (World Health Organisation, Geneva); 1965. p 23.
3. Fernandes C, Lalitha VS, Rao KVK. Enhancing effect of malachite green on the development of hepatic preneoplastic lesion induced by N-nitrosodiethylamine in rats. Carcinogenesis 1991;12:839.
4. Fernandes C, Rao KVK. Dose related promoter effect of metanil yellow on the development of hepatic preneoplastic lesions induced by N-nitrosodiethylamine in rats. Indian J Med Res 1994;100:140.
5. Rao KVK, Fernandes C. Progressive effects of malachite green at varying concentrations on the development of N-nitrosodiethylamine hepatic induced preneoplastic lesion in rats. Tumori 1996;82:280.
6. Rao KVK. Growth stimulatory effect of primary adult rat hepatocyte cultures by metanil yellow: a new liver promoter. In: Rao RS, Deo MG, Sanghvi LD, Mitra I, editors. Proceedings of the XVIth International Cancer Congress. New Delhi; 1994. p 77.
7. Rao KVK. Inhibition of DNA synthesis in primary rat hepatocyte cultures by malachite green: a new liver tumor promoter. Toxicol Lett 1995;81:107.
8. Hall M, Peters G. Genetic alterations of cyclin, cyclin dependent kinases and cdk inhibitors in human cancer. In: Woude GFV, Klein G. Advances in cancer research. New York: Academic Press; 1996. p 67-89.
9. Goodger NM, Gannon J, Hunt T, Morgan PR. Cell cycle regulatory proteins: an overview with relevance to oral cancer. Oral Oncology 1997;33:61-73.
10. Shackelford RE, Kaufmann WK, Paules RS. Cell cycle control, checkpoint mechanisms and genotoxic stress. Environmental Health Perspectives 1999;107:5-23.
11. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia in MMTV-cyclinD1 transgenic mice. Nature 1994;369:669-671.
12. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. Overexpression of cyclinB1 in early stage non-small lung cancer and its clinical implication. Cancer Res 2000;60:4000-4004.
13. Kawamoto H, Koizumi H, Uchikoshi T. Expression of the G2-M checkpoint regulators cyclinB1 and cdc2 in non-malignant and malignant breast lesions. Am. J Pathol 1997;150:15-23.
14. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A. Expression of cell cycle regulated proteins in prostate cancer. Cancer Res 1996;56:4159-4163.
15. Murakami H, Farihata M, Ohtusi Y, Ogoshi S. Determination of prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 1999;434:153-158.
16. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane D. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
17. Kang MJ, Kim MK, Terhune A, Park JK, Kin YH, Koh GY. Cytoplasmic localization of Cyclin D3 in seminiferous tubules during testicular development. Exp Cell Res 1997;234:27.
18. Petersons GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987;162:56-159.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
21. Ausubel FM, Brent R, Kingston RE, Moore DD, Seudnab JO, Smith JA, Struhl K. Identification of newly transcribed RNA. New York: John Wiley & Sons; 1995.
22. Sundarajan M, Fernandis AZ, Subrahmanyam G, Prabhudesai S, Krishnamurthy SC, Rao KVK. Overexpression of G1/S cyclins and PCNA and their relationship to tyrosine phosphorylation and dephosphorylation during tumor promotion by metanil yellow and malachite green. Toxicol Lett 2000;116:119-130.
23. Percino C, Fry RJM, Staffeldt EF, Christopher JP. Comparative enhancing effects of phenobarbital, anobarbital, diphenyl hydrantoin and dichlorodiphenyl trichloroethane on 2-acetyle amino flourene induced hepatic tumorigenesis in the rat. Cancer Res 1975;35:2884.
24. Shinozuka H, Lombardi B, Abanobi SE. A comparative study of the efficacy of four barbiturates as promoters of the development of γ-glutamyl transpeptidase positive loci in the liver of carcinogen treated rats. Carcinogenesis 1982;3:1017.
25. Diwan BA, Rice JM, Oshima M, Ward JM, Dove LF. Comparative tumor promoting activities of phenobarbital, anobarbital, barbital, sodium and barbituric acid on liver and other organs of male F344/Ncr rats following initiation with N-nitrosodiethylamine. J Natl Cancer Inst 1985;74:509.
26. Sawada N, Staecker JL, Pitot HC. Effects of tumor promoting agents 12-0-tetradecanoyl phorbol 13-acetate and phenobarbital on DNA synthesis of rat hepatocytes in primary culture. Cancer Res 1987;47:5665.
27. Hursting SD, Slaga TJ, Fischer SM, DiGiovnni J, Phang JM. Mechanism based cancer prevention approaches: targets, examples and use of transgenic mice. J Natl Cancer Inst 1999;91:215.
28. Dragan YP, Pitot HC. The role of the stages of initiation and promotion in phenotypic diversity during hepatocarcinogenesis in the rat. Carcinogenesis 1992;13:739-750.
29. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev (Cancer) 2001;1:222.
30. Weinstein LB. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 2000;21:857.
31. Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. Dose dependence of phenobarbitol promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 1996;17:947-954.
32. Diwan BA, Ward JM, Ramljak D, Anderson LM. Promotion of Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosomethylamine in male A/J Cr mice. Toxicol Pathol 1997;25:597-605.
33. Coupland SE, Bechrakis N, Schuler A, Anagnoslopoulos I, Hummel M, Bornfeld N, Stein H. Expression patterns of cyclinD1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Br J Opthalmol 1998;82:961-970.
34. Wang OS, Sabourin CL, Wang H, Stoner GD. Overexpression of cyclinD1 and cyclinE in N-nitrosomethylbenzylamine-induced rat eosophageal tumorigenesis. Carcinogenesis 1996;17:1583-1588.
35. O'Connor PM, Ferris DK, White GA, Pines J, Hunter T, Kohn KW. Relationship between cdc2 kinase DNA cross linking and cell cycle perturbations induced by nitrogen mustard. Cell Growth Diff 1992;3:43.
36. Peters JM, Aoyama T, Cattley RC, Nobumitsu U, Hashiomoto T, Gonzalez FJ. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 1998;19:1989-1994.
37. Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Rese 2000;80:542-545.